Reprogrammed Stem Cells Are Rife with Mutations
By Emily Singer,
Technology Review
| 03. 03. 2011
The findings cast doubt on a promising alternative to the use of embryonic stem cells in medicine.
Adult cells that have been reprogrammed into stem cells harbor a number of genetic mutations, some of which appear in genes that have been linked to cancer. While scientists don't yet know how this might affect the use of the cells in medicine, they say the findings show that the cells need to be studied much more extensively.
"As we think about using [these] cells for therapy, we will want to consider what kinds of screening tests we want to do," says Lawrence Goldstein, a professor of molecular biology at the University of California, San Diego. One of the major concerns about stem-cell-based therapies has been whether they carry a risk of cancer; both stem cells and cancer cells are distinguished by their ability to continually divide.
In two studies published today in Nature, researchers analyzed the genome of induced pluripotent stem (iPS) cells, adult cells that have been genetically or chemically reverted to the stem cell state. These cells have attracted intense interest from both scientists and the public as a potential alternative to embryonic stem cells. Like...
Related Articles
By Mike Baker, The New York Times | 02.25.2025
As investigators struggled for weeks to find who might have committed the brutal stabbings of four University of Idaho students in the fall of 2022, they were focused on a key piece of evidence: DNA on a knife sheath that...
By David Jensen, Capitol Weekly | 02.19.2025
California scientists took what looked like an $800 million hit last week in their efforts to develop revolutionary treatments and cures for diseases ranging from cancer to diabetes.
It was a jab from the Trump administration, one that generated apocalyptic...
By Patrick Foong, BioNews | 02.03.2025
Following a lengthy litigation, the co-founders of the Stem Cell Institute of America and related companies have been prohibited from promoting and selling stem cell therapies under a federal district court order. The court, in the case of Federal...
By Hannah Devlin, The Guardian | 01.26.2025
Mass-producing eggs and sperm in a laboratory in order to have a baby with yourself or three other people in a “multiplex” parenting arrangement might sound like the plot of a dystopian novel.
But these startling scenarios are under consideration...
